Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

Conditions:   Rhabdomyosarcoma;   Rhabdomyosarcoma- Alveolar;   Rhabdomyosarcoma-Embryonal Interventions:   Drug: Dasatinib;   Drug: Ganitumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting - verified January 25, 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials